dnth: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	275,242	729
Increase/(decrease) in cash, cash equivalents and restricted cash	33,129	-9,554
Cash and cash equivalents at beginning of period	23,022	-
Cash and cash equivalents at end of period	56,151	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	275,242	729
Increase/(decrease) in cash, cash equivalents and restricted cash	33,129	-9,554
Cash and cash equivalents at beginning of period	23,022	-
Cash and cash equivalents at end of period	56,151	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Dianthus Therapeutics, Inc. DE (DNTH)